Search for: "In Re: Pharmaceutical, et al"
Results 1 - 20
of 288
Sort by Relevance
|
Sort by Date
9 May 2024, 11:30 am
For the Balkinization symposium on David Pozen, The Constitution of the War on Drugs (Oxford University Press, 2024).Paul Butler Like most users of illegal drugs, I have never been caught. [read post]
22 Apr 2024, 5:00 am
Many state and local officials host social media sites and use them to converse with followers on matters related to their governmental responsibilities, among other things.[1] Not surprisingly, many choose to block from their sites certain members of the public they find disagreeable.[2] Being disagreeable, or at least in disagreement with such actions, blocked followers sometimes sue alleging that their exclusion violates the First Amendment.[3] One of the most notable examples was a… [read post]
3 Apr 2024, 9:05 pm
Tex. 2001). [7] See Torben Andersen et al., A Descriptive Study of High-Frequency Trade and Quote Options Data, 19 J. [read post]
28 Feb 2024, 2:00 pm
” (Green et al., Reference Guide on Epidemiology, in Reference Manual on Scientific Evidence (3d ed. 2011) 549, 552, 598.) [read post]
23 Jan 2024, 11:32 am
"Another way software is different is because software involves creating computer code that can be re-used for other purposes. [read post]
9 Jan 2024, 7:06 am
Salix Pharmaceuticals et al. v. [read post]
19 Nov 2023, 2:31 pm
Chubin et al. at 10, Daubert v. [read post]
19 Dec 2022, 2:31 am
NPR, Al Jazeera and CNN cover the claim. [read post]
29 Aug 2022, 9:05 pm
Since President Biden issued his July 2021 Executive Order on Competition, the antitrust agencies have made broad policy statements promising more aggressive enforcement and have initiated a number of high-profile enforcement actions. [read post]
24 Aug 2022, 4:00 am
Pour ce faire, une liste non limitative de quatre critères est établie : . . . [read post]
19 Jul 2022, 2:59 pm
In the following guest post, the authors revisit the question of whether or not securities class action lawsuits against development-stage biotech companies are likelier to survive a motion to dismiss compared to securities suits against other kinds of companies. [read post]
15 Jul 2022, 10:09 am
Lythgoe MP, Desai A, et al. [read post]
19 Jun 2022, 5:05 pm
Although lawyers are known as a querulous lot, statisticians may not be far behind. [read post]
17 Jun 2022, 2:09 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), legal scholars, judges, and lawyers have struggled with the structure and validity of expert opinion on specific causation. [read post]
23 Mar 2022, 9:03 am
Vertesi et al. write, “Critical engagements typically embrace intersections between IT research and corporations yet eschew immediate pay-offs for companies or designers. [read post]
20 Mar 2022, 4:42 pm
Cette condition correspond à l'art. 12 al. 3 LPM. [read post]
14 Mar 2022, 11:23 am
Inc. et al. v. [read post]
5 Jan 2022, 7:16 am
The case, In Re Valsartan, Losartan, and Irbesartan Products Liability Litigation (US DC NJ) MDL No. 2875 (RBK)is a products liability case that concerns the sale in the U.S. of generic, prescription Valsartan pharmaceuticals, found by the Food and Drug Administration [“FDA”] to contain cancer‐causing contaminants. [read post]
4 Oct 2021, 1:52 pm
Post-AIA (Point Estimate) We thank LaTia Brand of Harrity Analytics and the Stanford NPE Database, described in Shawn Miller et al., Who’s Suing Us? [read post]
4 Oct 2021, 1:52 pm
Post-AIA (Point Estimate) We thank LaTia Brand of Harrity Analytics and the Stanford NPE Database, described in Shawn Miller et al., Who’s Suing Us? [read post]
